Adagio Seeks Authority for Another Reverse Split, Up to 1-for-1,000
ADGM sits 23% above its 52-week low of $1.5 on elevated volume (1.9× avg).
Summary
Adagio Medical is asking shareholders to approve a reverse split of up to 1-for-1,000, just days after completing a 1-for-30 split, to keep its stock above Nasdaq's minimum bid price. The special meeting is set for December 2026 with a November 16 record date.
Key Events · Corporate Governance and Compliance · ADGM
-
New Reverse Split Authorization Sought
Preliminary proxy asks stockholders to approve a charter amendment permitting a reverse split of up to 1-for-1,000, implementable on one or more occasions within 12 months, with the exact ratio set by the board.
-
Follows Just-Executed 1-for-30 Split
The November 6, 2026 1-for-30 reverse split took effect and split-adjusted trading began November 9, 2026; the new request is larger than the previously approved 1-for-10 to 1-for-500 range.
-
Delisting Risk If Proposal Fails
The proxy states that without the authority, the board cannot raise the per-share price to satisfy Nasdaq's minimum bid requirement, exposing the stock to delisting.
-
Convertible Notes Could Force More Splits
The filing warns that alternate conversions of the Convertible Securities Notes could issue substantially more shares at discounted prices, depress the stock, and necessitate additional reverse splits.
Analysis · ADGM · Industrial Applications And Services
Adagio just executed a 1-for-30 reverse split on November 6, 2026, and is already back asking shareholders for permission to do more — up to an aggregate 1-for-1,000, on one or more occasions over the next 12 months. That is a candid admission that the last split may not hold the share price above Nasdaq's $1.00 minimum bid. The company is burning cash with a going-concern warning and runway only into Q4 2026, and the proxy itself flags that alternate conversions of its convertible notes could dump more shares and force additional splits. Shareholders are effectively voting on whether to keep handing the board a delisting-avoidance tool; a 'no' vote removes the board's main lever to stay listed.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADGM was trading at $1.84 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $1.50 to $50.70. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.